Cardiogenic Shock due to Pulseless Electrical Activity Arrest Associated with Severe Coronary Artery Spasm

Shozo Sueda1, Kaori Fujimoto1, Yasuhiro Sasaki1

  • 1Department of Cardiology, Ehime Niihama Prefectural Hospital, Japan.

Insights

A patient experienced cardiogenic shock during coronary angiography due to severe coronary artery blockages. Prompt cardiopulmonary support and cardiac massage successfully restored blood pressure, highlighting the importance of immediate intervention in such critical cardiac events.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Critical Care Medicine

Background:

  • Coronary angiography is a standard procedure for diagnosing coronary artery disease.
  • Catastrophic cardiogenic shock can occur during invasive cardiac procedures.
  • Pulseless electrical activity (PEA) arrest is a critical emergency requiring immediate resuscitation.

Observation:

  • A 75-year-old male patient developed ST-segment elevation myocardial infarction and cardiogenic shock immediately upon initiating coronary angiography.
  • Left coronary arteriogram revealed critical obstructions: total occlusion of the left anterior descending artery and subtotal occlusion of the left circumflex artery.
  • The patient presented with pulseless electrical activity arrest, necessitating cardiopulmonary support and prolonged cardiac massage.

Findings:

  • Successful resuscitation was achieved after over 15 minutes of cardiac massage, with blood pressure returning to baseline.
  • Notably, neither ventricular fibrillation nor ventricular tachycardia was observed during the event, distinguishing it from typical shock rhythms.
  • The findings underscore a rare presentation of cardiogenic shock and PEA arrest secondary to acute coronary artery occlusion during angiography.

Implications:

  • This case highlights the critical need for preparedness and rapid response protocols in interventional cardiology settings.
  • Understanding the hemodynamics of PEA arrest in the context of acute coronary syndromes is crucial for effective management.
  • Further research may elucidate specific risk factors or mechanisms leading to PEA arrest during angiography in patients with severe coronary artery disease.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
516
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
3.8K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
298
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
411
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
733